Paya Carlos V 4

What Happened
Carlos V. Paya, a director of Collegium Pharmaceutical, Inc. (COLL), was granted 8,741 restricted stock units (RSUs) on May 14, 2026. The award is reported at $0.00 on the Form 4 because it is a contingent equity grant (transaction code A). Each RSU represents a contingent right to one share of common stock and will convert into shares when settled.

Key Details

• Transaction date: May 14, 2026; Filing date: May 18, 2026 (filed within the standard two-business-day Form 4 window).
• Transaction type/code: Grant/Award (A); reported price: $0.00.
• Shares/units granted: 8,741 RSUs (1 RSU = 1 share upon settlement).
• Shares owned after transaction: Not specified in this filing.
• Footnote: RSUs vest on the earlier of May 14, 2027 or the Issuer's 2027 Annual Meeting, subject to continued board service. RSUs may be settled in shares on the vesting date or earlier upon the director’s election in cases of service termination, death/disability, or a change in control.

Context
This is a compensation-related equity award for board service, not an open-market purchase or sale. RSUs are contingent and do not represent immediately tradable shares until settled upon vesting or other qualifying events. Such grants are routine for directors and reflect compensation rather than a direct trading signal.